SCHEMBL10240934

SCHEMBL10240934

O/N=C(\CC(c1ccccc1)c1ccccc1)c1cc(Cl)ncc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 4/20 0.38
NPSR1 Q6W5P4 2/20 0.35
HTT P42858 1/20 0.35
TACR1 P25103 2/20 0.34
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
MGLL Q99685 1/20 0.32
ALDH1A1 P00352 1/20 0.32
BUB1 O43683 1/20 0.31
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31
CTSA P10619 1/20 0.30
HTR1B P28222 1/20 0.30
HRH1 P35367 1/20 0.30
POLB P06746 1/20 0.30
MAPK1 P28482 1/20 0.30
DCAF1 Q9Y4B6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL364475 1.00 GPBAR1 (0.38) GPBAR1NPSR1HTTTACR1MAPT
SCHEMBL364474 1.00 GPBAR1 (0.38) GPBAR1NPSR1HTTTACR1MAPT
SCHEMBL10241042 0.82 GPBAR1 (0.52) GPBAR1CTSA
SCHEMBL363807 0.82 GPBAR1 (0.52) GPBAR1CTSA
SCHEMBL1389623 0.82 GPBAR1 (0.52) GPBAR1CTSA
SCHEMBL10290808 0.81 NPSR1 (0.39) NPSR1HTTTACR1MAPTKDM4E
SCHEMBL363060 0.81 NPSR1 (0.42) NPSR1HTTTACR1MAPTKDM4E
SCHEMBL364369 0.79 GPBAR1 (0.38) GPBAR1NPSR1HTTTACR1MAPT
SCHEMBL364368 0.79 GPBAR1 (0.38) GPBAR1NPSR1HTTTACR1MAPT
SCHEMBL10240932 0.79 GPBAR1 (0.38) GPBAR1NPSR1HTTTACR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885NPSR1 319/4885HTT 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.